Effect of sacubitril–valsartan on cardiac function in hemodialysis patients
- 30 July 2021
- journal article
- letter
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 26 (1) , 244-245
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction with End-Stage of Renal DiseaseESC Heart Failure, 2020
- Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection FractionJAMA, 2019
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- Measuring risk in end-stage renal disease: Is N-terminal pro brain natriuretic peptide a useful marker?Kidney International, 2007